Isabell Bernlochner

3.6k total citations
62 papers, 1.4k citations indexed

About

Isabell Bernlochner is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Internal Medicine. According to data from OpenAlex, Isabell Bernlochner has authored 62 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Cardiology and Cardiovascular Medicine, 28 papers in Surgery and 19 papers in Internal Medicine. Recurrent topics in Isabell Bernlochner's work include Antiplatelet Therapy and Cardiovascular Diseases (45 papers), Acute Myocardial Infarction Research (21 papers) and Venous Thromboembolism Diagnosis and Management (19 papers). Isabell Bernlochner is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (45 papers), Acute Myocardial Infarction Research (21 papers) and Venous Thromboembolism Diagnosis and Management (19 papers). Isabell Bernlochner collaborates with scholars based in Germany, Italy and United States. Isabell Bernlochner's co-authors include Dirk Sibbing, Adnan Kastrati, Karl‐Ludwig Laugwitz, Tanja Morath, Wolfgang Siess, S. Schulz, Albert Schömig, Robert A. Byrne, Julinda Mehilli and Katharina Mayer and has published in prestigious journals such as Annals of Internal Medicine, Journal of the American College of Cardiology and Scientific Reports.

In The Last Decade

Isabell Bernlochner

56 papers receiving 1.4k citations

Peers

Countries citing papers authored by Isabell Bernlochner

Since Specialization

Citations

This map shows the geographic impact of Isabell Bernlochner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabell Bernlochner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabell Bernlochner more than expected).

Fields of papers citing papers by Isabell Bernlochner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabell Bernlochner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabell Bernlochner. The network helps show where Isabell Bernlochner may publish in the future.

Co-authorship network of co-authors of Isabell Bernlochner

This figure shows the co-authorship network connecting the top 25 collaborators of Isabell Bernlochner. A scholar is included among the top collaborators of Isabell Bernlochner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabell Bernlochner. Isabell Bernlochner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Platelet–leukocyte aggregates in cardiovascular disease: prognostic significance and therapeutic potential 2025 ·Cardiovascular Research ·Jiaying Han, Conor J. Bloxham, (unknown), Giacomo Viggiani, (unknown), Moritz von Scheidt, (unknown), Isabell Bernlochner, Gianluigi Condorelli, Philip Raake, Dario Bongiovanni	0
2	Necessity of dental restoration before heart valve replacement: a cross-sectional study of a historical cohort 2025 ·Clinical Oral Investigations ·Lucas M. Ritschl, Isabell Bernlochner, Andreas Keßler, Klaus‐Dietrich Wolff, Herbert Deppe	0
3	Plasma Soluble Glycoprotein VI, Platelet Function, Bleeding, and Ischemic Events in Patients Undergoing Elective Percutaneous Coronary Intervention 2023 ·Thrombosis and Haemostasis ·(unknown), Kristin Adler, Katharina Mayer, (unknown), Isabell Bernlochner, Gjin Ndrepepa, Stefanie Schüpke, Stefan Holdenrieder, Dario Bongiovanni, Karl‐Ludwig Laugwitz, Heribert Schunkert, Meinrad Gawaz, Steffen Maßberg, Adnan Kastrati, Götz Münch	4
4	Reticulated Platelets Predict Cardiovascular Death and Adverse Events in Coronary Artery Disease: A Systematic Review and Meta-analysis 2023 ·Thrombosis and Haemostasis ·Mauro Chiarito, Isabell Bernlochner, Dario Bongiovanni, (unknown), (unknown), (unknown), Jiaying Han, Bastian Wein, (unknown), Giacomo Viggiani, Moritz von Scheidt, Karl‐Ludwig Laugwitz, Philip Raake, Adnan Kastrati	6
5	Immature Platelet Fraction Predicts Adverse Events in Patients With Acute Coronary Syndrome: the ISAR-REACT 5 Reticulated Platelet Substudy 2022 ·Arteriosclerosis Thrombosis and Vascular Biology ·Dario Bongiovanni, (unknown), (unknown), Katharina Mayer, Dominick J. Angiolillo, Dirk Sibbing, Stefan Holdenrieder, (unknown), Moritz von Scheidt, Heribert Schunkert, Karl‐Ludwig Laugwitz, Stefanie Schüpke, Adnan Kastrati, (unknown), Isabell Bernlochner	13
6	Platelet Surface Protein Expression and Reactivity upon TRAP Stimulation after BNT162b2 Vaccination 2021 ·Thrombosis and Haemostasis ·(unknown), Olga Lazareva, (unknown), Marc Rosenbaum, Marina Lukas, (unknown), Christoph D. Spinner, Moritz von Scheidt, (unknown), Jan Baumbach, Jürgen Ruland, Gianluigi Condorelli, Karl‐Ludwig Laugwitz, Markus List, Isabell Bernlochner, Dario Bongiovanni	10
7	SARS-CoV-2 infection is associated with a pro-thrombotic platelet phenotype 2021 ·Cell Death and Disease ·Dario Bongiovanni, (unknown), Olga Lazareva, (unknown), (unknown), Simona Ursu, Sarah Warth, Christian Buske, Marina Lukas, Christoph D. Spinner, Moritz von Scheidt, Gianluigi Condorelli, Jan Baumbach, Karl‐Ludwig Laugwitz, Markus List, Isabell Bernlochner	71
8	Twelve-month clinical outcomes in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention: insights from the ISAR-REACT 5 trial 2021 ·European Heart Journal Acute Cardiovascular Care ·J J Coughlan, (unknown), Gjin Ndrepepa, Stefanie Schüpke, Isabell Bernlochner, Katharina Mayer, Franz‐Josef Neumann, Maurizio Menichelli, Gert Richardt, Jochen Wöhrle, Erion Xhepa, Sebastian Kufner, Hendrik B. Sager, Michael Joner, Tareq Ibrahim, Massimiliano Fusaro, Karl‐Ludwig Laugwitz, Heribert Schunkert, Adnan Kastrati, Salvatore Cassese	3
9	Mass cytometry of platelet-rich plasma: a new approach to analyze platelet surface expression and reactivity 2021 ·Platelets ·(unknown), (unknown), Jiaying Han, Olga Lazareva, Marc Rosenbaum, Giacomo Viggiani, Moritz von Scheidt, Jürgen Ruland, Jan Baumbach, Gianluigi Condorelli, Karl‐Ludwig Laugwitz, Markus List, Isabell Bernlochner, Dario Bongiovanni	6
10	Influence of diagnosis of venous thromboembolism on immature platelets, absolute platelet count and platelet aggregation over time 2020 ·Platelets ·(unknown), (unknown), Nicolas Langwieser, Bernhard Haller, Peter B. Luppa, Christian Bradaric, Dario Bongiovanni, Anja Stundl, Karl‐Ludwig Laugwitz, Tareq Ibrahim, Isabell Bernlochner	5
11	Influence of antiretroviral therapy and cardiovascular disease on the immature platelet fraction in patients living with HIV 2019 ·Platelets ·Alexander Goedel, (unknown), (unknown), Alexander Zink, Sebastian Noé, Dario Bongiovanni, Bernhard Haller, Christoph D. Spinner, Isabell Bernlochner	5
12	Real clinical experiences of dual versus triple antithrombotic therapy after percutaneous coronary intervention 2018 ·Catheterization and Cardiovascular Interventions ·(unknown), Nikolaus Sarafoff, Bernhard Haller, (unknown), Dirk Sibbing, Stefanie Schüpke, Tareq Ibrahim, (unknown), Heribert Schunkert, Karl‐Ludwig Laugwitz, Adnan Kastrati, Isabell Bernlochner	1
13	Ticagrelor versus prasugrel in patients with high on-clopidogrel treatment platelet reactivity after PCI: The ISAR-ADAPT-PF study 2016 ·Platelets ·Isabell Bernlochner, Katharina Mayer, Martin Orban, Tanja Morath, (unknown), (unknown), Lisa Groß, Karl‐Ludwig Laugwitz, Adnan Kastrati, Dirk Sibbing	7
14	Impact of bivalirudin on post-procedural epicardial blood flow, risk of stent thrombosis and mortality after percutaneous coronary intervention 2016 ·EuroIntervention ·K. Anette Fiedler, Gjin Ndrepepa, S. Schulz, (unknown), Petra Hoppmann, Sebastian Kufner, Isabell Bernlochner, Robert A. Byrne, Heribert Schunkert, Karl‐Ludwig Laugwitz, Adnan Kastrati	1
15	Aspirin Treatment and Outcomes After Percutaneous Coronary Intervention 2014 ·Journal of the American College of Cardiology ·Katharina Mayer, Isabell Bernlochner, Siegmund Braun, S. Schulz, Martin Orban, Tanja Morath, (unknown), Petra Hoppmann, Heribert Schunkert, Karl‐Ludwig Laugwitz, Adnan Kastrati, Dirk Sibbing	73
16	Prognostic Value of a High On-Clopidogrel Treatment Platelet Reactivity in Bivalirudin Versus Abciximab Treated Non–ST-Segment Elevation Myocardial Infarction Patients 2012 ·Journal of the American College of Cardiology ·Dirk Sibbing, Isabell Bernlochner, S. Schulz, Steffen Maßberg, Albert Schömig, Julinda Mehilli, Adnan Kastrati	29
17	PLATELET FUNCTION TESTING GUIDED USE OF PRASUGREL IN PATIENTS WITH HIGH ON-CLOPIDOGREL TREATMENT PLATELET REACTIVITY REDUCES THE RISK OF EARLY STENT THROMBOSIS 2012 ·Journal of the American College of Cardiology ·Dirk Sibbing, Katharina Mayer, Isabell Bernlochner, Tanja Morath, (unknown), (unknown), Jöerg Hausleiter, Adnan Kastrati	3
18	Thienopyridines and Other ADP-Receptor Antagonists 2012 ·Handbook of experimental pharmacology ·Isabell Bernlochner, Dirk Sibbing	22
19	High platelet reactivity and clinical outcome – Fact and fiction 2011 ·Thrombosis and Haemostasis ·Dirk Sibbing, Robert A. Byrne, Isabell Bernlochner, Adnan Kastrati	50
20	A 2-Step Mechanism of Arterial Thrombus Formation Induced by Human Atherosclerotic Plaques 2010 ·Journal of the American College of Cardiology ·Armin J. Reininger, Isabell Bernlochner, Sandra Penz, Catherine Ravanat, Peter A. Smethurst, Richard W. Farndale, Christian Gachet, Richard Brandl, Wolfgang Siess	145

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact